Screenshot of the Santé BD website:

Accessing healthcare services for autistic people can be a significant barrier, as they may face discrimination, communication difficulties, sensory sensitivities, lack of predictability, etc. Research has also shown that autistic people have higher rates of co-occurring conditions, which is why supporting autistic people in accessing healthcare is key.

Santé BD is an online digital platform for people with disabilities (including autism) as well as their families and healthcare professionals. It provides different posters, comics, videos, and flyers explaining different medical procedures, conditions, as well as prevention information regarding healthcare. The platform enables the user to personalise the comics with different profiles (such as man, woman, girl, boy, wheelchair user, autistic person) for better patient engagement. By using these materials, autistic people are able learn about healthcare information and procedures in a more accessible way. For healthcare professionals and relatives, these resources enable them to communicate more effectively about health with their relatives or patients.

The platform is available in French, English, Spanish, Romanian, German, and Arabic. It is available here.

Gibalica: Virtual Fitness Coach

Screenshots from the Gibalica App (Google Play)

The Gibalica application works as a virtual fitness coach. It covers areas of education, physical activities and health, as well as leisure. It is free and available without registration for Android. In addition to exercise and encouraging motor activity, it can also be used to learn the terms left and right. It was created as part of the project ‘Competency Network Based on Information and Communication Technologies for innovative services for persons with complex communication needs (ICT-AAC)’. An application evaluation system for evaluation of applications intended for users on the autism spectrum was used to assess the application (Sistema de indicadores de evaluación de aplicaciones destinadas a personas usuarias con TEA; Gallardo-Montes et al., 2021).